Leishmania Recidivans Could Be Induced by Intralesional Infiltration of Cutaneous Leishmaniasis by Sodium Stibogluconate, with New Therapeutic Trial
Journal of Clinical and Experimental Investigations · 2022
DOI: 10.29333/jcei/11516 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical and Experimental Investigations, 2022. Verfasst von Khalifa E Sharquie und 1 weiteren Autor:innen. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 35 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Sharquie, K. E., & Jabbar, R. I. (2022). Leishmania Recidivans Could Be Induced by Intralesional Infiltration of Cutaneous Leishmaniasis by Sodium Stibogluconate, with New Therapeutic Trial. Journal of Clinical and Experimental Investigations. https://doi.org/10.29333/jcei/11516
Vancouver
Sharquie KE, Jabbar RI. Leishmania Recidivans Could Be Induced by Intralesional Infiltration of Cutaneous Leishmaniasis by Sodium Stibogluconate, with New Therapeutic Trial. Journal of Clinical and Experimental Investigations. 2022. doi:10.29333/jcei/11516
BibTeX
@article{Sharquie2022,
author = {Sharquie, Khalifa E and Jabbar, Raed I},
title = {Leishmania Recidivans Could Be Induced by Intralesional Infiltration of Cutaneous Leishmaniasis by Sodium Stibogluconate, with New Therapeutic Trial},
journal = {Journal of Clinical and Experimental Investigations},
year = {2022},
doi = {10.29333/jcei/11516}
}
EUVIMED